Gonzalo Fernández-Miranda: Incredible 5 days at the Neurofibromatosis 2024 Global NF Conference

Gonzalo Fernández-Miranda, Founder in Residence at Deep Science Ventures, shared a post on LinkedIn:

“What an incredible 5 days at the Neurofibromatosis 2024 Global NF Conference in Brussels with nearly 1,000 attendees!!!!

We were privileged to discuss cutting-edge science with the brightest minds dedicated to end NF.

Key takeaways from the Conference:

• The NF community is incredibly united and strong.
• The Children’s Tumor Foundation is doing an exceptional job keeping everyone united and focused on what truly matters to patients.
• Patients and families are phenomenal examples of resilience and motivation.
• Gene Therapies in their various modalities can make a real difference.

A heartfelt thank you to researchers and clinicians Harish Vasudevan, Eduard Serra, Piotr Topilko, Said Farschtschi, Hector Salvador, Santiago Vernia, Dusica Babovic-Vuksanovic, Hagit Toledano-Alhadef, to Children’s Tumor Foundation, Annette Bakker, Marco Nievo, Mary Brigid Garelik and to patients and families for transmitting your energy and passion Pamela Shen, Krizelle Alcantara, Simone Manso.

After more than 1 year of careful venture preparation by Deep Science Ventures and Children’s Tumor Foundation, we believe there is great momentum to launch our gene therapy company for NF.

Together, we will End NF!”  .

Source: Gonzalo Fernández-Miranda/LinkedIn